These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7912475)

  • 1. Different effects between antihypertensive drugs on nephrotic-range proteinuria in renovascular hypertension.
    Ishimitsu T; Yagi H; Ohkubo M; Nakamura Y; Yagi S
    Am J Nephrol; 1994; 14(1):60-3. PubMed ID: 7912475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt.
    DeQuattro V; Lee DP
    Cardiology; 1997; 88 Suppl 3():38-42. PubMed ID: 9397292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
    Redon J; Rovira E; Miralles A; Julve R; Pascual JM
    Hypertension; 2002 Mar; 39(3):794-8. PubMed ID: 11897766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic-range proteinuria in a patient with high renin hypertension: effect of treatment with an ACE-inhibitor.
    Docci D; Moscatelli G; Capponcini C; Baldrati L; Feletti C
    Am J Nephrol; 1992; 12(5):387-9. PubMed ID: 1489013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disappearance of renin-induced proteinuria by an ACE-inhibitor: a case report.
    Holman ND; Donker AJ; van der Meer J
    Clin Nephrol; 1990 Aug; 34(2):70-1. PubMed ID: 2225556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
    Remuzzi A; Schieppati A; Battaglia C; Remuzzi G
    Am J Kidney Dis; 1989 Sep; 14(3):170-7. PubMed ID: 2476029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.
    Garini G; Mazzi A; Buzio C; Mutti A; Allegri L; Savazzi G; Borghetti A
    Nephrol Dial Transplant; 1996 Apr; 11(4):628-34. PubMed ID: 8671850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy of renovascular hypertension.
    Rosenthal T
    Drugs; 1993 Jun; 45(6):895-909. PubMed ID: 7691497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotic-range proteinuria in patients with renovascular disease.
    Halimi JM; Ribstein J; Du Cailar G; Mimran A
    Am J Med; 2000 Feb; 108(2):120-6. PubMed ID: 11126305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
    Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA; Khosla N; Bakris GL
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-dose nifedipine on urinary protein excretion rate in patients with renal disease.
    Kloke HJ; Wetzels JF; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1998 Mar; 13(3):646-50. PubMed ID: 9550641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.